CD8A and metastatic melanoma: In metastatic melanoma, a progressive enrichment of tumor-specific CD45RA+CCR7+CD95+CD8+ TSCM with high-avidity TCR was observed in the blood of patients having received monthly doses of native peptide-based vaccine [78], suggesting the transferability of the concept in humans (Figure 3).